WO2002101002A3 - Identification of snps the hgv-v gene - Google Patents

Identification of snps the hgv-v gene Download PDF

Info

Publication number
WO2002101002A3
WO2002101002A3 PCT/EP2002/008919 EP0208919W WO02101002A3 WO 2002101002 A3 WO2002101002 A3 WO 2002101002A3 EP 0208919 W EP0208919 W EP 0208919W WO 02101002 A3 WO02101002 A3 WO 02101002A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
hgv
snps
identification
snp
Prior art date
Application number
PCT/EP2002/008919
Other languages
French (fr)
Other versions
WO2002101002A2 (en
Inventor
Jean-Louis Escary
Original Assignee
Genodyssee
Jean-Louis Escary
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01402435A external-priority patent/EP1295938A1/en
Application filed by Genodyssee, Jean-Louis Escary filed Critical Genodyssee
Priority to AU2002327824A priority Critical patent/AU2002327824A1/en
Publication of WO2002101002A2 publication Critical patent/WO2002101002A2/en
Publication of WO2002101002A3 publication Critical patent/WO2002101002A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormones [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to new polynucleotides deriving from the nucleotide sequence of the hGH-V gene and comprising SNP(s), new polypeptides comprising a mutation caused by this (these) SNP(s) as well as their therapeutic uses.
PCT/EP2002/008919 2001-06-07 2002-06-07 Identification of snps the hgv-v gene WO2002101002A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002327824A AU2002327824A1 (en) 2001-06-07 2002-06-07 Identification of snps the hgv-v gene

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US29614901P 2001-06-07 2001-06-07
US60/296,149 2001-06-07
EP01402435.0 2001-09-21
EP01402435A EP1295938A1 (en) 2001-09-21 2001-09-21 Corrected sequence of the hGH-V gene and an allelic variant
US32540101P 2001-09-27 2001-09-27
US60/325,401 2001-09-27

Publications (2)

Publication Number Publication Date
WO2002101002A2 WO2002101002A2 (en) 2002-12-19
WO2002101002A3 true WO2002101002A3 (en) 2003-09-04

Family

ID=27224395

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/008919 WO2002101002A2 (en) 2001-06-07 2002-06-07 Identification of snps the hgv-v gene

Country Status (2)

Country Link
AU (1) AU2002327824A1 (en)
WO (1) WO2002101002A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0229850D0 (en) * 2002-12-20 2003-01-29 Ares Trading Sa Splice variant
WO2005018659A2 (en) * 2003-08-20 2005-03-03 Neuren Pharmaceuticals Limited Somatogenic therapy using a 20kda placental variant of growth hormone
WO2006012525A2 (en) * 2004-07-23 2006-02-02 Neuren Pharmaceuticals Limited Non-diabetogenic therapy using a 20kda placental growth hormone variant
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy
US10953074B2 (en) * 2017-01-08 2021-03-23 Richard D. Lippman Composition and method for improving sensorineural hearing

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020398A1 (en) * 1994-01-27 1995-08-03 Human Genome Sciences, Inc. Human growth hormone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020398A1 (en) * 1994-01-27 1995-08-03 Human Genome Sciences, Inc. Human growth hormone

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
BARTLETT SYLVIA ET AL: "Alkaline-mediated differential interaction (AMDI): A simple automatable single-nucleotide polymorphism assay.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 98, no. 5, 27 February 2001 (2001-02-27), February 27, 2001, pages 2694 - 2697, XP002185148, ISSN: 0027-8424 *
DATABASE ENTREZ SNP [online] 13 September 2000 (2000-09-13), XP002234490, retrieved from NCBI Database accession no. rs1130670 *
DATABASE ENTREZ SNP [online] 13 September 2000 (2000-09-13), XP002234491, retrieved from NCBI Database accession no. rs1130686 *
DATABASE ENTREZ SNP [online] 13 September 2000 (2000-09-13), XP002234492, retrieved from NCBI Database accession no. rs1058053 *
DATABASE ENTREZ SNP [online] 13 September 2000 (2000-09-13), XP002234493, retrieved from NCBI Database accession no. rs1058051 *
DATABASE ENTREZ SNP [online] 13 September 2000 (2000-09-13), XP002234494, retrieved from NCBI Database accession no. rs1050724 *
DATABASE ENTREZ SNP [online] 13 September 2000 (2000-09-13), XP002234495, retrieved from NCBI Database accession no. rs1050840 *
DATABASE ENTREZ SNP [online] 13 September 2000 (2000-09-13), XP002234496, retrieved from NCBI Database accession no. rs1048692 *
DATABASE OMIM [online] 18 March 1999 (1999-03-18), "GROWTH HORMONE 2; GH2", XP002234497, retrieved from NCBI Database accession no. 139240 *
LEHNERT VALERIE ET AL: "A semi-automated system for analysis and storage of SNPs.", HUMAN MUTATION, vol. 17, no. 4, 2001, pages 243 - 254, XP002185149, ISSN: 1059-7794 *
NICKERSON DEBORAH A ET AL: "PolyPhred: Automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 25, no. 14, 1997, pages 2745 - 2751, XP002152564, ISSN: 0305-1048 *

Also Published As

Publication number Publication date
AU2002327824A1 (en) 2002-12-23
WO2002101002A2 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
WO2002085940A3 (en) New polynucleotides and polypeptides of the erythropoietin gene
NO20042570L (en) Antimicrobial polypeptides from Pseudoplectania nigrella
AU2003291962A1 (en) Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same
CY1107335T1 (en) New Polynucleotides and Polypeptides of the IFNα-17 Gene
EP2302042A3 (en) Polypeptides having lipase activity and polynucleotides encoding same
WO2004023092A3 (en) Genetic analysis and authentication
WO2004099228A3 (en) Variants of beta-glucosidases
EP2295544A3 (en) Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same
WO2001023575A3 (en) Wuschel (wus) gene homologs
WO2004044132A3 (en) Modified oligonucleotides for use in rna interference
WO2005001064A3 (en) Polypeptides having alpha-amylase activity and polypeptides encoding same
WO2002079249A3 (en) New polynucleotides and polypeptides of the ifn$g(a)-21 gene
WO1999053040A3 (en) Human nucleic acid sequences from ovarian tumour tissue
AU2003254597A1 (en) Dna chip based genetic typing
WO2004007664A3 (en) Nucleic acid vectors
WO2006005032A3 (en) Polypeptides having alpha-glucosidase activity and polynucleotides encoding same
WO2002095067A3 (en) INTERFERON α-14 POLYMORPHISM
WO2002101002A3 (en) Identification of snps the hgv-v gene
WO2003000896A3 (en) POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE
WO2002101048A3 (en) NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
WO2004108757A3 (en) Antimicrobial polypeptides
WO2002083733A3 (en) Polynucleotides and polypeptides of the ifnalpha-6 gene
WO2000078958A3 (en) Scorpion toxins from buthotus judaicus
WO2000075340A3 (en) Magnesium chelatase
EP1236800A3 (en) Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP